MC-12, an Annexin A1-Based Peptide, Is Effective in the Treatment of Experimental Colitis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MC-12, an Annexin A1-Based Peptide, Is Effective in the Treatment of Experimental Colitis
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 7, Pages e41585
Publisher
Public Library of Science (PLoS)
Online
2012-07-24
DOI
10.1371/journal.pone.0041585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in eicosanoid research, novel therapeutic implications
- (2010) Jesper Z. Haeggström et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Annexin 1 Induced by Anti-Inflammatory Drugs Binds to NF- B and Inhibits Its Activation: Anticancer Effects In vitro and In vivo
- (2010) Z. Zhang et al. CANCER RESEARCH
- Soybean and fish oil mixture increases IL-10, protects against DNA damage and decreases colonic inflammation in rats with dextran sulfate sodium (DSS) colitis
- (2010) Karina V Barros et al. Lipids in Health and Disease
- Optimizing the safety of biologic therapy for IBD
- (2010) Shanika de Silva et al. Nature Reviews Gastroenterology & Hepatology
- Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer
- (2010) S Danese et al. ONCOGENE
- Control of free arachidonic acid levels by phospholipases A2 and lysophospholipid acyltransferases
- (2009) Gema Pérez-Chacón et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?
- (2009) Helenie Kefalakes et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Evolving Inflammatory Bowel Disease Treatment Paradigms: Top-Down Versus Step-Up
- (2009) Shane M. Devlin et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Evolving paradigms in the pathogenesis of IBD
- (2009) Lloyd Mayer JOURNAL OF GASTROENTEROLOGY
- Fos Proteins Suppress Dextran Sulfate Sodium-Induced Colitis through Inhibition of NF- B
- (2009) Y. Takada et al. JOURNAL OF IMMUNOLOGY
- Effect of COX-2 inhibitor after TNBS-induced colitis in wistar rats
- (2009) Ana Paula Ribeiro Paiotti et al. JOURNAL OF MOLECULAR HISTOLOGY
- Myeloperoxidase-Positive Cell Infiltration in Colorectal Carcinogenesis as Indicator of Colorectal Cancer Risk
- (2008) L. Roncucci et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- NO-donating aspirin inhibits the activation of NF-κB in human cancer cell lines and Min mice
- (2008) Jennie L. Williams et al. CARCINOGENESIS
- Cytokines: From Gut Inflammation to Colorectal Cancer
- (2008) Massimo Fantini et al. CURRENT DRUG TARGETS
- Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis
- (2008) Ken-Ichiro Tanaka et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- ROS, Hsp27, and IKKβ mediate dextran sodium sulfate (DSS) activation of IκBa, NFκB, and IL-8
- (2008) Sumit Bhattacharyya et al. INFLAMMATORY BOWEL DISEASES
- NF-κB in inflammatory bowel disease
- (2008) I. Atreya et al. JOURNAL OF INTERNAL MEDICINE
- Role of cytokines in inflammatory bowel disease
- (2008) Fausto Sanchez-Muñoz et al. WORLD JOURNAL OF GASTROENTEROLOGY
- NF-κB and the intestine: Friend or foe?
- (2007) Thomas Karrasch et al. INFLAMMATORY BOWEL DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now